Stage III Non–Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors

Abstract

Purpose:To determine whether quantitative imaging features from pretreatment positron emission tomography (PET) can enhance patient overall survival risk stratification beyond what can be achieved with conventional prognostic factors in patients with stage III non-small cell lung cancer (NSCLC). Materials and Methods:The institutional review board approved this retrospective chart review study and waived the requirement to obtain informed consent. The authors retrospectively identified 195 patients with stage III NSCLC treated definitively with radiation therapy between January 2008 and January 2013. All patients underwent pretreatment PET/computed tomography before treatment. Conventional PET metrics, along with histogram, shape and volume, and co-occurrence matrix features, were extracted. Linear predictors of overall survival were developed from leaveone-out cross-validation. Predictive Kaplan-Meier curves were used to compare the linear predictors with both quantitative imaging features and conventional prognostic factors to those generated with conventional prognostic factors alone. The Harrell concordance index was used to quantify the discriminatory power of the linear predictors for survival differences of at least 0, 6, 12, 18, and 24 months. Models were generated with features present in more than 50% of the cross-validation folds. Results:Linear predictors of overall survival generated with both quantitative imaging features and conventional prognostic factors demonstrated improved risk stratification compared with those generated with conventional prognostic factors alone in terms of log-rank statistic (P = .18 vs P = .0001, respectively) and concordance index (0.62 vs 0.58, respectively). The use of quantitative imaging features selected during cross-validation improved the model using conventional prognostic factors alone (P = .007). Disease solidity and primary tumor energy from the co-occurrence matrix were found to be selected in all folds of cross-validation. Conclusion:Pretreatment PET features were associated with overall survival when adjusting for conventional prognostic factors in patients with stage III NSCLC.q RSNA, 2015

PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology

“…High SUV peak2mL and Gauss cluster shade Laws are associated with an increased risk of distant metastases 84 .Solidity (which quantifies the dispersion of primary and nodal disease in a local region, with high values corresponding to disease that is compact and in close proximity, and low values corresponding to disease that is dispersed) and primary tumor energy GLCM (higher level for tumors that are more heterogeneous) improve risk stratification compared with a model with conventional prognostic factors alone in stage III NSCLC. Solidity and primary tumor energy GLCM are capable of isolating subgroups of patients who will receive a benefit or detriment from dose escalation (i.e., as disease solidity and primary co-occurrence matrix energy increase, patients receiving higher dose radiation therapy have improved OS and PFS compared with those receiving lower doses) 81, 82 .Adk: adenocarcinoma type; AUC-IVH: area under the curve within the intensity volume histogram; DFS: disease-free survival; DSS: disease-specific survival; GLCM: gray-level co-occurrence matrix; GLRLM: gray-level run-length matrix; GLSZM: gray-level size-zone matrix; Gr: absolute gradient; LPFS: local progression-free survival; MTV: metabolic tumor volume; NGTDM: neighborhood gray-tone difference matrix; NSCLC: non-small cell lung cancer; OS: overall survival; PFS: progression-free survival; Sqc: squamocellular types; SUV: standardized uptake value. …”

Early-Stage Non–Small Cell Lung Cancer: Quantitative Imaging Characteristics of18F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis

“…The rationale is that, by extracting a large number of putative imaging features, we could obtain a more comprehensive characterization of the underlying tumor phenotypes, which may ultimately correlate with clinical outcomes. This approach has been used to predict overall survival in patients with lung cancer with widely available imaging data such as CT (11,12) or FDG PET (13,14).…”

Pretreatment18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235

“…A recent single-institution analysis identified several textural features that were associated with OS in a cohort of stage III NSCLC patients who were treated with definitive radiotherapy (28). Strengths of this study include a large sample size and the inclusion of disease volume in survival models as an established prognostic factor.…”